Skip to main content
Erschienen in: Obesity Surgery 4/2021

03.01.2021 | Original Contributions

Intestinal Electrical Stimulation Alters Hypothalamic Expression of Oxytocin and Orexin and Ameliorates Diet-Induced Obesity in Rats

verfasst von: Shiying Li, Yeram Kim, Jiande D. Z. Chen, Mohammad F. Madhoun

Erschienen in: Obesity Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Intestinal electrical stimulation (IES) has been proposed as a potential treatment for obesity. The aim of this study was to explore the central mechanism underlying the reduction of food intake and body weight by IES by studying the expression of anorexigenic- and orexigenic-peptide-containing neurons in the hypothalamus.

Materials and Methods

Diet-induced obese (DIO) rats were divided into three groups to receive sham, IES, and pair-feeding for 4 weeks. Food intake was measured automatically and presented as daily and body weight measured weekly. The expressions of oxytocin, an anorexigenic neuropeptide, in the paraventricular nucleus of the hypothalamus (PVN) and the supraoptic nuclei of the hypothalamus (SON) and orexin-A, an orexigenic neuropeptide, in the lateral hypothalamic area (LHA) were studied using immunohistochemistry.

Results

Compared with sham, IES reduced daily food intake by 28.3% at week 1, 35.6% at week 2, 15.6% at week 3, and 27.1% at week 4. Consistently, IES reduced body weight by 6.3%, compared with a weight gain of 7.2% in sham, and a slight weight loss of 0.5% in pair-feeding. Compared with sham, IES increased the expression of oxytocin-immunoreactive neurons in PVN and SON. Compared with sham, IES decreased the expression of orexin-immunoreactive neurons in LHA. Rats with pair-feeding also showed a relative decease in weight without any changes in the central hormones.

Conclusion

IES reduces food intake and body weight and improves glucose tolerance and insulin sensitivity in DIO rats. Its central mechanisms involve enhancement of anorexigenic peptides and suppression of orexigenic peptides in the hypothalamus.
Literatur
1.
Zurück zum Zitat Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50.PubMedCrossRef Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50.PubMedCrossRef
2.
Zurück zum Zitat Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health J Int Soc Pharmacoecon Outcomes Res. 2016;19(5):602–13.CrossRef Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health J Int Soc Pharmacoecon Outcomes Res. 2016;19(5):602–13.CrossRef
3.
Zurück zum Zitat De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.PubMedPubMedCentralCrossRef De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Dargent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg. 2002;12(Suppl 1):21S–5S.CrossRef Dargent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg. 2002;12(Suppl 1):21S–5S.CrossRef
7.
Zurück zum Zitat Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12(Suppl 1):12S–6S.PubMedCrossRef Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12(Suppl 1):12S–6S.PubMedCrossRef
8.
Zurück zum Zitat Greenstein RJ, Belachew M. Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete. Obes Surg. 2002;12(Suppl 1):3S–5S.PubMedCrossRef Greenstein RJ, Belachew M. Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete. Obes Surg. 2002;12(Suppl 1):3S–5S.PubMedCrossRef
9.
Zurück zum Zitat Favretti F, De Luca M, Segato G, et al. Treatment of morbid obesity with the transcend implantable gastric stimulator (IGS): a prospective survey. Obes Surg. 2004;14(5):666–70.PubMedCrossRef Favretti F, De Luca M, Segato G, et al. Treatment of morbid obesity with the transcend implantable gastric stimulator (IGS): a prospective survey. Obes Surg. 2004;14(5):666–70.PubMedCrossRef
10.
Zurück zum Zitat Horbach T, Thalheimer A, Seyfried F, et al. Abiliti closed-loop gastric electrical stimulation system for treatment of obesity: clinical results with a 27-month follow-up. Obes Surg. 2015;25(10):1779–87.PubMedPubMedCentralCrossRef Horbach T, Thalheimer A, Seyfried F, et al. Abiliti closed-loop gastric electrical stimulation system for treatment of obesity: clinical results with a 27-month follow-up. Obes Surg. 2015;25(10):1779–87.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Xu X, Lei Y, Chen JDZ. Duodenum electrical stimulation delays gastric emptying, reduces food intake and accelerates small bowel transit in pigs. Obes Silver Spring Md. 2011;19(2):442–8.CrossRef Xu X, Lei Y, Chen JDZ. Duodenum electrical stimulation delays gastric emptying, reduces food intake and accelerates small bowel transit in pigs. Obes Silver Spring Md. 2011;19(2):442–8.CrossRef
12.
Zurück zum Zitat Li S, Chen JDZ. Pulse width-dependent effects of intestinal electrical stimulation for obesity: role of gastrointestinal motility and hormones. Obes Surg. 2017;27(1):70–7.PubMedCrossRef Li S, Chen JDZ. Pulse width-dependent effects of intestinal electrical stimulation for obesity: role of gastrointestinal motility and hormones. Obes Surg. 2017;27(1):70–7.PubMedCrossRef
13.
Zurück zum Zitat Sun Y, Chen J. Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity. Obes Res. 2004;12(8):1235–42.PubMedPubMedCentralCrossRef Sun Y, Chen J. Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity. Obes Res. 2004;12(8):1235–42.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Aberle J, Busch P, Veigel J, et al. Duodenal electric stimulation: results of a first-in-man study. Obes Surg. 2016;26(2):369–75.PubMedCrossRef Aberle J, Busch P, Veigel J, et al. Duodenal electric stimulation: results of a first-in-man study. Obes Surg. 2016;26(2):369–75.PubMedCrossRef
15.
Zurück zum Zitat Yin J, Zhang J, Chen JDZ. Inhibitory effects of intestinal electrical stimulation on food intake, weight loss and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol. 2007;293(1):R78–82.PubMedCrossRef Yin J, Zhang J, Chen JDZ. Inhibitory effects of intestinal electrical stimulation on food intake, weight loss and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol. 2007;293(1):R78–82.PubMedCrossRef
16.
Zurück zum Zitat Tang M, Zhang J, Xu L, et al. Implantable gastric stimulation alters expression of oxytocin- and orexin-containing neurons in the hypothalamus of rats. Obes Surg. 2006;16(6):762–9.PubMedCrossRef Tang M, Zhang J, Xu L, et al. Implantable gastric stimulation alters expression of oxytocin- and orexin-containing neurons in the hypothalamus of rats. Obes Surg. 2006;16(6):762–9.PubMedCrossRef
17.
Zurück zum Zitat Allen YS, Adrian TE, Allen JM, et al. Neuropeptide Y distribution in the rat brain. Science. 1983;221(4613):877–9.PubMedCrossRef Allen YS, Adrian TE, Allen JM, et al. Neuropeptide Y distribution in the rat brain. Science. 1983;221(4613):877–9.PubMedCrossRef
18.
Zurück zum Zitat Park ES, Yi SJ, Kim JS, et al. Changes in orexin-A and neuropeptide Y expression in the hypothalamus of the fasted and high-fat diet fed rats. J Vet Sci. 2004;5(4):295–302.PubMedCrossRef Park ES, Yi SJ, Kim JS, et al. Changes in orexin-A and neuropeptide Y expression in the hypothalamus of the fasted and high-fat diet fed rats. J Vet Sci. 2004;5(4):295–302.PubMedCrossRef
20.
Zurück zum Zitat Arletti R, Benelli A, Bertolini A. Oxytocin inhibits food and fluid intake in rats. Physiol Behav. 1990;48(6):825–30.PubMedCrossRef Arletti R, Benelli A, Bertolini A. Oxytocin inhibits food and fluid intake in rats. Physiol Behav. 1990;48(6):825–30.PubMedCrossRef
21.
Zurück zum Zitat Rinaman L, Rothe EE. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiol Regul Integr Comp Physiol. 2002;283(1):R99–106.PubMedCrossRef Rinaman L, Rothe EE. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiol Regul Integr Comp Physiol. 2002;283(1):R99–106.PubMedCrossRef
22.
Zurück zum Zitat Olson BR, Drutarosky MD, Chow MS, et al. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides. 1991;12(1):113–8.PubMedCrossRef Olson BR, Drutarosky MD, Chow MS, et al. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides. 1991;12(1):113–8.PubMedCrossRef
23.
Zurück zum Zitat Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.PubMedCrossRef Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.PubMedCrossRef
24.
Zurück zum Zitat Farley C, Cook JA, Spar BD, et al. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res. 2003;11(7):845–51.PubMedCrossRef Farley C, Cook JA, Spar BD, et al. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res. 2003;11(7):845–51.PubMedCrossRef
25.
Zurück zum Zitat Zhang J, Maude-Griffin R, Zhu H, et al. Gastric electrical stimulation parameter dependently alters ventral medial hypothalamic activity and feeding in obese rats. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G912–8.PubMedCrossRef Zhang J, Maude-Griffin R, Zhu H, et al. Gastric electrical stimulation parameter dependently alters ventral medial hypothalamic activity and feeding in obese rats. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G912–8.PubMedCrossRef
26.
Zurück zum Zitat Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 1994;17(2):152–4.PubMedCrossRef Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 1994;17(2):152–4.PubMedCrossRef
27.
Zurück zum Zitat Zhang G, Bai H, Zhang H, et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron. 2011;69(3):523–35.PubMedPubMedCentralCrossRef Zhang G, Bai H, Zhang H, et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron. 2011;69(3):523–35.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Shikora SA, Bergenstal R, Bessler M, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2009;5(1):31–7.CrossRef Shikora SA, Bergenstal R, Bessler M, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2009;5(1):31–7.CrossRef
29.
Zurück zum Zitat Madsen AN, Hansen G, Paulsen SJ, et al. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol. 2010;206(3):287–96.PubMedCrossRef Madsen AN, Hansen G, Paulsen SJ, et al. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol. 2010;206(3):287–96.PubMedCrossRef
30.
Zurück zum Zitat Maejima Y, Yokota S, Nishimori K, et al. The anorexigenic neural pathways of oxytocin and their clinical implication. Neuroendocrinology. 2018;107(1):91–104.PubMedCrossRef Maejima Y, Yokota S, Nishimori K, et al. The anorexigenic neural pathways of oxytocin and their clinical implication. Neuroendocrinology. 2018;107(1):91–104.PubMedCrossRef
32.
Zurück zum Zitat Altirriba J, Poher A-L, Rohner-Jeanrenaud F. Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity. Front Endocrinol. 2015;6:119.CrossRef Altirriba J, Poher A-L, Rohner-Jeanrenaud F. Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity. Front Endocrinol. 2015;6:119.CrossRef
33.
Zurück zum Zitat Morton GJ, Thatcher BS, Reidelberger RD, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab. 2012;302(1):E134–44.PubMedCrossRef Morton GJ, Thatcher BS, Reidelberger RD, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab. 2012;302(1):E134–44.PubMedCrossRef
35.
Zurück zum Zitat Deblon N, Veyrat-Durebex C, Bourgoin L, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One. 2011;6(9):e25565.PubMedPubMedCentralCrossRef Deblon N, Veyrat-Durebex C, Bourgoin L, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One. 2011;6(9):e25565.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Blais A, Drouin G, Chaumontet C, et al. Impact of orexin-A treatment on food intake, energy metabolism and body weight in mice. PLoS One. 2017;12(1):e0169908.PubMedPubMedCentralCrossRef Blais A, Drouin G, Chaumontet C, et al. Impact of orexin-A treatment on food intake, energy metabolism and body weight in mice. PLoS One. 2017;12(1):e0169908.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Van den Pol AN. Lateral hypothalamic damage and body weight regulation: role of gender, diet, and lesion placement. Am J Phys. 1982;242(3):R265–74. Van den Pol AN. Lateral hypothalamic damage and body weight regulation: role of gender, diet, and lesion placement. Am J Phys. 1982;242(3):R265–74.
38.
Zurück zum Zitat Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron. 1999;24(4):941–51.PubMedCrossRef Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron. 1999;24(4):941–51.PubMedCrossRef
40.
Zurück zum Zitat Liu J, Qiao X, Hou X, et al. Effect of intestinal pacing on small bowel transit and nutrient absorption in healthy volunteers. Obes Surg. 2009;19(2):196–201.PubMedCrossRef Liu J, Qiao X, Hou X, et al. Effect of intestinal pacing on small bowel transit and nutrient absorption in healthy volunteers. Obes Surg. 2009;19(2):196–201.PubMedCrossRef
41.
Zurück zum Zitat Sun Y, Chen JDZ. Intestinal electric stimulation accelerates whole gut transit and promotes fat excrement in conscious rats. Int J Obes 2005. 2009;33(8):817–23. Sun Y, Chen JDZ. Intestinal electric stimulation accelerates whole gut transit and promotes fat excrement in conscious rats. Int J Obes 2005. 2009;33(8):817–23.
42.
Zurück zum Zitat Li S, Zhu W, Zhang S, et al. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet-induced obesity rats. Obes Silver Spring Md. 2017;25(6):1061–8.CrossRef Li S, Zhu W, Zhang S, et al. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet-induced obesity rats. Obes Silver Spring Md. 2017;25(6):1061–8.CrossRef
43.
Zurück zum Zitat Näslund E, Gutniak M, Skogar S, et al. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998;68(3):525–30.PubMedCrossRef Näslund E, Gutniak M, Skogar S, et al. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998;68(3):525–30.PubMedCrossRef
44.
Zurück zum Zitat Roslin MS, Cripps CN. Bariatric surgery in managing diabetes mellitus. Curr Opin Gastroenterol. 2016;32(6):481–6.PubMedCrossRef Roslin MS, Cripps CN. Bariatric surgery in managing diabetes mellitus. Curr Opin Gastroenterol. 2016;32(6):481–6.PubMedCrossRef
45.
Metadaten
Titel
Intestinal Electrical Stimulation Alters Hypothalamic Expression of Oxytocin and Orexin and Ameliorates Diet-Induced Obesity in Rats
verfasst von
Shiying Li
Yeram Kim
Jiande D. Z. Chen
Mohammad F. Madhoun
Publikationsdatum
03.01.2021
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 4/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05177-w

Weitere Artikel der Ausgabe 4/2021

Obesity Surgery 4/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.